Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

Gene Therapy

Volumn 10, Issue 26, 2003, Pages 2105-2111

  Wang, Z ^a   Ma, H I ^a,b   Li, J ^a   Sun, L ^a   Zhang, J ^a   Xiao, X ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

AAV; Double stranded; dsAAV; Gene therapy; Vector

Indexed keywords

ANGIOSTATIN; COMPLEMENTARY DNA; DOUBLE STRANDED DNA; GREEN FLUORESCENT PROTEIN; PLASMID DNA; RESTRICTION ENDONUCLEASE; SINGLE STRANDED DNA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC STABILITY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INVERTED TERMINAL REPEAT; LIVER; LIVER CELL; LUNG CANCER; MELANOMA CELL; MOLECULAR MECHANICS; MOUSE; MUSCLE TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME;

ANIMALS; BLOTTING, SOUTHERN; CELL LINE, TUMOR; DEPENDOVIRUS; DNA REPLICATION; DNA, SINGLE-STRANDED; DNA, VIRAL; GENETIC VECTORS; GENOME, VIRAL; HEPATOCYTES; HUMANS; MUTATION; TRANSDUCTION, GENETIC; TRANSGENES;

ADENO-ASSOCIATED VIRUS; ANIMALIA; DNA VIRUSES;

EID: 0348038748     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302133     Document Type: Article

References (31)

1. Samulski RJ, Sally M, Muzyczka N. Adeno-associated viral vectors. In: Friedmann T (ed). Development of Human Gene Therapy. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1999, pp 131-172.
2. Ferrari FK, Samulski T, Shenk T, Samulski RJ. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 1996; 70: 3227-3234.
3. Fisher KJ et al. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 1996; 70: 520-532.
4. Nakai H, Storm TA, Kay MA. Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo. J Virol 2000; 74: 9451-9463.
5. Lewin AS et al. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa [published erratum appears in Nat Med 1998 Sep;4(9):1081]. Nat Med 1998; 4: 967-971.
6. Ma HI et al. Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin. Cancer Res 2002; 62: 756-763.
7. Shimazaki K et al. Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal death. Gene Therapy 2000; 7: 1244-1249.
8. Miao CH et al. Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction. J Virol 2000; 74: 3793-3803.
9. Song S et al. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Therapy 2001; 8: 1299-1306.
10. Mount JD et al. Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy. Blood 2002; 99: 2670-2676.
11. Chao H, Mao L, Bruce AT, Walsh CE. Sustained expression of human factor VIII in mice using a parvovirus-based vector. Blood 2000; 95: 1594-1599.
12. Xu L et al. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice. Hum Gene Ther 2001; 12: 563-573.
13. Qing K et al. Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc Natl Acad Sci USA 1997; 94: 10879-10884.
14. Duan D et al. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest 2000; 105: 1573-1587.
15. McCarty DM, Monahan PE, Samulski RJ. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Therapy 2001; 8: 1248-1254.
16. Hirata RK, Russell DW. Design and packaging of adeno-associated virus gene targeting vectors. J Virol 2000; 74: 4612-4620.
17. King JA, Dubielzig R, Grimm D, Kleinschmidt JA. DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. EMBO J 2001; 20: 3282-3291.
18. Clark KR, Liu X, McGrath JP, Johnson PR. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum Gene Ther 1999; 10: 1031-1039.
19. Girod A et al. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat Med 1999; 5: 1052-1056.
20. Hansen J, Qing K, Srivastava A. Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J Virol 2001; 75: 4080-4090.
21. Nakai H et al. A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction. J Virol 2002; 76: 11343-11349.
22. Hansen J et al. Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J Virol 2000; 74: 992-996.
23. Duan D et al. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue [published erratum appears in J Virol 1999 Jan;73(1):861]. J Virol 1998; 72: 8568-8577.
24. Wang JC, Lynch AS. Transcription and DNA supercoiling. Curr Opin Genet Dev 1993; 3: 764-768.
25. Flotte TR et al. Gene expression from adeno-associated virus vectors in airway epithelial cells. Am J Respir Cell Mol Biol 1992; 7: 349-356.
26. Song S, Laipis PJ, Berns KI, Flotte TR. Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle. Proc Natl Acad Sci USA 2001; 98: 4084-4088.
27. Nakai H et al. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J Virol 2001; 75: 6969-6976.
28. Xiao X et al. Adeno-associated virus (AAV) vector antisense gene transfer in vivo decreases GABA(A) alpha1 containing receptors and increases inferior collicular seizure sensitivity. Brain Res 1997; 756: 76-83.
29. McCaffrey AP et al. RNA interference in adult mice. Nature 2002; 418: 38-39.
30. Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224-2232.
31. Snyder R, Xiao X, Samulski RJ. Production of recombinant adeno-asociated viral vectors. In: Smith D (ed). Current Protocols in Human Genetics. John Wiley & Sons Ltd: New York, 1996: